QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
See you tomorrow at SHEA?
We are looking forward to a lively discussion tomorrow during our session” Will TLV‘s new framework strengthen access to orphan drugs” lead by Konstantin Macheridis, a parallel discussion to Quantify’s contributions to the EFPIA – European Federation of Pharmaceutical Industries and Associations‘ W.A.I.T. report in collaboration with Lif – de forskande läkemedelsföretagen.
Looking forward to seeing you […]
Welcome to the team, Natassia!
We are excited to welcome Natassia Robinson, PhD to the Quantify Research team!
- Natassia holds a PhD in Molecular Epidemiology from Newcastle University in England. She conducted postdoctoral research in cancer epigenetics (Newcastle University) and psychiatric genetic epidemiology (Karolinska Institutet).
- During […]
ISPOR is coming up!
In just a few short weeks, the Quantify Research team will be on site at ISPORannual in Montreal.
Our team, Emilie Toresson Grip, Puneet Kaushik, Abraham Choong, and Kirk Geale, PhD – together with athagoras Group colleagues from IGES Lifescience – is looking forward to meeting clients and partner […]
Why Pharmacovigilance Data Quality Matters
In pharmacovigilance, high-quality data isn’t just about meeting regulatory checkboxes, it’s a vital cornerstone in protecting patient safety.
When pharmacovigilance falls short, the repercussions can be severe, from misleading safety statistics to, in the worst cases, preventable harm or even death. That’s why data quality is front and center, and the Nordic region offers a compelling example of how robust data can make a real difference.
Although Nordic countries represent just […]